Viral Learning Curve
Drug manufacturers are racing to create a protective measure against coronavirus without destroying the patient’s immune system
Medicine793 articles archived since 1845
The Coronavirus Outbreak Could Make it Quicker and Easier to Trial Drugs
Remote clinical trials and other changes could permanently alter pharmaceutical development
COVID-19 Is Forcing Us to Rethink Clinical Trials for Cancer Treatments
Participation rates were already low, but the pandemic threatens to drive them even lower
Vaccinations Have Sharply Declined Nationwide during the COVID-19 Pandemic
Rates of childhood immunization have fallen across the U.S., raising the risk of vaccine-preventable disease outbreaks
Hospitals Experiment with COVID-19 Treatments, Balancing Hope and Evidence
With little data on what works and what doesn’t, doctors trade tips and argue about risks
Common Steroid Could Be Cheap and Effective Treatment for Severe COVID-19
The results of a trial that found dexamethasone reduced the risk of death in extremely ill coronavirus patients have yet to be published, but some doctors are already embracing them
Artificial nanoparticles are not as good as the real thing
Philip W. Askenase explains why naturally occurring exosomes are better for drug discovery.
How extracellular vesicles can enhance drug delivery
In exosomes, our bodies have an efficient means of transmitting RNA information. Researchers want to use it to deliver drugs.
Inside the stem-cell pharmaceutical factory
Vesicles secreted by stem cells might give clinicians a safer and simpler alternative to cell therapy, but researchers are still grappling with how best to prepare and study these tiny particles...
A Visual Guide to the SARS-CoV-2 Coronavirus
What scientists know about the inner workings of the pathogen that has infected the world
How to Transport Crucial Vaccines without Cooling
Unlike vials, flexible films could preserve medicines for long periods, with no refrigeration needed
Coronavirus Antibody Therapies Raise Hopes—and Skepticism
Some experts caution we should temper our expectations about the much-touted approach
COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’
Biotechs and pharma want to protect patients without triggering immune system havoc
Early Coronavirus Immunity Data Fuel Promise for a Vaccine
Researchers found COVID-19 infection produces a strong T cell response. Here’s why they say that is good news
Malaria Mosquitoes Are Biting before Bed-Net Time
Mosquitoes that like to bite at night are being thwarted by bed nets, leading to the rise of populations that prefer to bite when the nets are not up yet.
Coronavirus Vaccine Trials Have Delivered Their First Results—but Their Promise Is Still Unclear
Scientists urge caution over hints of success emerging from small human and animal studies
Medical Euthanasia Brings New Questions for Researchers
Some individuals choosing physician-assisted death donate their tissue to science.
From Hamsters to Baboons: The Animals Helping Scientists Understand the Coronavirus
Different species are helping answer different questions about COVID-19 in humans in order to develop vaccines and treatments
Early Detection: A New Front in the War on Cancer
Blood tests that find malignancies before they spread could transform our approach to treatment...
The Fight against COVID-19 Threatens to Cause Collateral Health Damage
The pandemic is no excuse to abandon chronic disease management and prevention
